| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Anti Cancer Drugs (Q3) | ||
| Dergi ISSN | 0959-4973 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | Türkçe | Basım Tarihi | 01-2025 |
| Cilt / Sayı / Sayfa | 36 / 3 / 208–219 | DOI | 10.1097/CAD.0000000000001679 |
| Makale Linki | https://doi.org/10.1097/cad.0000000000001679 | ||
| Özet |
| This study explores the therapeutic potential of albumin-bound Zn (II)-thiosemicarbazone compounds (Alb-ZnTcA, Alb-ZnTcB) against breast cancer cells. Previous research indicates that these compounds hinder cancer cell proliferation by blocking DNA synthesis, promoting oxidative stress to induce apoptosis, and disrupting the cell cycle to inhibit cellular division. This study focuses on the loading and characterization of these potentially chemically unstable compounds on bovine serum albumin-based nanocarriers. Accordingly, unlike previous studies using albumin nanoparticles, in this study, ultraviolet light was used to precisely bind the therapeutic agent to albumin during the integration of thiosemicarbazones, achieving controlled nanoparticle size to control nanoparticle size. The mean diameter of Alb-ZnTcA nanoparticles was 32 nm, while Alb-ZnTcB exhibited an average diameter of 43 nm. Notably, Alb … |
| Anahtar Kelimeler |
| breast cancer treatment | nanoparticles | research & development | thiosemicarbazone-bovine serum albumin | thiosemicarbazones | zinc |
| Atıf Sayıları | |
| Web of Science | 3 |
| Scopus | 3 |
| Google Scholar | 4 |
| Dergi Adı | ANTI-CANCER DRUGS |
| Yayıncı | Lippincott Williams and Wilkins |
| Açık Erişim | Hayır |
| ISSN | 0959-4973 |
| E-ISSN | 1473-5741 |
| CiteScore | 4,1 |
| SJR | 0,532 |
| SNIP | 0,421 |